Diabetes is a global epidemic affecting an estimated 422 million people worldwide.
WHO projects diabetes will be the 7th leading cause of death by 2030.
An estimated 4 million people die annually from diabetes complications.
Taking insulin is often part of treating diabetes. Sterile, single-use HTL-STREFA PEN NEEDLES are intended to be used with a pen injector device for the subcutaneous injection of insulin. They are commonly used by people with diabetes who often require multiple daily insulin injections.
Many people with diabetes still find injecting of insulin as an unpleasant and painful process which may cause poor disease control. The proper injection technique helps diabetic patients to achieve the best possible health outcomes by ensuring that the correct dose of medication is delivered to the correct injection site, using the correct needle size.
Sterility is guaranteed if the needle seal is unbroken. The tip of the needle may be damaged with reuse.
This can increase the chance of experiencing pain when injecting as the needle tip is dulled; used needles also increase infection risk and cause possible needle clogging and inaccurate dosing.